R

Relmada Thera (RLMD)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Relmada Thera (RLMD)

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCa... Read more

  • USD4.09
  • USD4.26
  • USD4.07
  • USD38.68
  • 22.60%
  • --
  • 220.55k
  • 393.09k
  • 124M
  • 1.81
  • -75.40%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.